Esperion Therapeutics Inc.
ESPR
Market Cap$215.98M
Close$
$11.14
1178.7% upside
Current Fair Value
1178.7% upsideUndervalued by 1178.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $215.98 Million |
|---|---|
| Enterprise Value | $377.34 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.28 |
| Beta | 0.86 |
| Outstanding Shares | 191,056,343 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.02 |
|---|---|
| PEG | 14.16 |
| Price to Sales | 0.87 |
| Price to Book Ratio | -0.29 |
| Enterprise Value to Revenue | 1.28 |
| Enterprise Value to EBIT | 22.99 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | -0.79 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Esperion Therapeutics Inc.
CEO: Timothy Mayleben